Akari Therapeutics ( NASDAQ: AKTX ) announced the initial closing of a private placement financing round, in which it has raised an aggregate of ~$7.6 million in gross proceeds from both new and existing investors. The company added the majority of the private placement financing was supported by new investors, with continued support from certain existing investors.
More on Akari Therapeutics Akari gains despite leadership change amid portfolio shakeup Financial information for Akari Therapeutics.